Cannabis industry
-
Trump’s Order Moves Marijuana to Schedule III: What It Means for Patients, Businesses, and Federal Law
President Trump’s executive order reclassifies marijuana as a Schedule III drug, marking a pivotal shift in U.S. drug policy. The move promises tax relief for cannabis businesses, expanded medical research, and potential Medicare coverage for CBD, but leaves recreational use…
-
Weed Stocks Surge as Trump Moves to Loosen U.S. Marijuana Restrictions
Weed stocks, led by Canopy Growth, soared after reports that President Trump plans to reclassify marijuana as a less-restricted drug. While investors cheered, questions remain about long-term profitability and the true impact of the policy shift.
-
Congress Moves to Ban Intoxicating Hemp: Industry and States Brace for Impact
A sweeping federal crackdown on intoxicating hemp products, slipped into legislation to reopen the government, has ignited fierce debate among farmers, regulators, and business owners, threatening to upend a $28 billion industry and override state laws.